Table 4.
CMR findings comparing patient with vs. without adverse remodelling
| STEMI, n = 49 | |||
|---|---|---|---|
| Adverse remodelling, n = 18 (37%) | Non‐adverse remodelling, n = 31 (63%) | P | |
| Baseline | |||
| EF (%) | 48 ± 11 | 47 ± 9 | 0.868 |
| EDVi (mL/m2) | 68 ± 13 | 70 ± 13 | 0.427 |
| ESVi (mL/m2) | 35 ± 13 | 37 ± 13 | 0.471 |
| SV/i (mL/m2) | 32 ± 6 | 33 ± 6 | 0.726 |
| LVmass/i (g/m2) | 59 ± 11 | 64 ± 13 | 0.289 |
| AAR (%) | 32 ± 23 | 22 ± 18 | 0.070 |
| IS (%) | 23 ± 16 | 15 ± 11 | 0.030 |
| MVO, n (%) | 7 (39%) | 17 (54%) | 0.462 |
| Transmurality, n (%) | 10 (56%) | 9 (29%) | 0.09 |
| 4 months FU | |||
| LVEF (%) | 45 ± 11 | 53 ± 8 | 0.060 |
| EDV/i (mL/m2) | 87 ± 27 | 66 ± 15 | 0.053 |
| ESV/i (mL/m2) | 50 ± 25 | 31 ± 12 | 0.005 |
| SV/i (mL/m2) | 37 ± 7 | 36 ± 6 | 0.726 |
| LVmass/i (g/m2) | 54 ± 11 | 60 ± 11 | 0.326 |
| IS (%) | 16 ± 14 | 12 ± 10 | 0.580 |
AAR, area at risk; EDVi, end‐diastolic volume index; ESVi, end‐systolic volume index; IS, infarct size; LVEF, left ventricular ejection fraction; LVmass/i, left ventricular mass index; MVO, microvascular obstruction; SVi, stroke volume index; STEMI, segment elevation myocardial infarction.